Haitian
English French German Portuguese Spanish Russian Japanese Korean Arabic Irish Greek Turkish Italian Danish Romanian Indonesian Czech Afrikaans Swedish Polish Basque Catalan Esperanto Hindi Lao Albanian Amharic Armenian Azerbaijani Belarusian Bengali Bosnian Bulgarian Cebuano Chichewa Corsican Croatian Dutch Estonian Filipino Finnish Frisian Galician Georgian Gujarati Haitian Hausa Hawaiian Hebrew Hmong Hungarian Icelandic Igbo Javanese Kannada Kazakh Khmer Kurdish Kyrgyz Latin Latvian Lithuanian Luxembou.. Macedonian Malagasy Malay Malayalam Maltese Maori Marathi Mongolian Burmese Nepali Norwegian Pashto Persian Punjabi Serbian Sesotho Sinhala Slovak Slovenian Somali Samoan Scots Gaelic Shona Sindhi Sundanese Swahili Tajik Tamil Telugu Thai Ukrainian Urdu Uzbek Vietnamese Welsh Xhosa Yiddish Yoruba Zulu Kinyarwanda Tatar Oriya Turkmen Uyghur
Leave Your Message
Pwodwi yo

Telechaje Materyèl

Telechaje Materyèl

Telechajman COA io1
non pwodwi Nimewo atik la Sitasyon Lyen literati
Non pwodwi: Pwoteyin imen rekombinan bFGF Nimewo atik: GMP-TL901 GNPNAT1 ankouraje devlopman kansè nan tete epi li sèvi kòm yon potansyèl byomarkè pronostik. https://www.spandidos-publications.com/10.3892/or.2023.8594
Non pwodwi: Pwoteyin EGF imen rekombinan Nimewo atik: GMP-TL613 GNPNAT1 ankouraje devlopman kansè nan tete epi li sèvi kòm yon potansyèl byomarkè pronostik. https://www.spandidos-publications.com/10.3892/or.2023.8594
non pwodwi: Twous Kilti Selilè AMMS®MSC 2.0 Nimewo atik: AS-13 Pwopriyete Selilè Amelyore nan Selil Souch Pulp Dantè Imen (hDPSC) Izole ak Elaji nan yon Mwayen Konfòm GMP ak Ksenojèn san Serom https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10621445/
non pwodwi: Pwoteyin IL-7 imen rekombinan Nimewo atik: GMP-TL506 Reseptè II TGFβ negatif dominan ak TIM3 tronke amelyore efikasite antitimoral terapi selil CAR-T nan kansè pwostat. https://www.sciencedirect.com/science/article/pii/S1567576923011323
non pwodwi: Pwoteyin IL-15 imen rekombinan Nimewo atik: GMP-TL202 Reseptè II TGFβ negatif dominan ak TIM3 tronke amelyore efikasite antitimoral terapi selil CAR-T nan kansè pwostat. https://www.sciencedirect.com/science/article/pii/S1567576923011323
non pwodwi: Pwoteyin IL-21 imen rekombinan Nimewo atik: GMP-TL509 Reseptè II TGFβ negatif dominan ak TIM3 tronke amelyore efikasite antitimoral terapi selil CAR-T nan kansè pwostat. https://www.sciencedirect.com/science/article/pii/S1567576923011323
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 Reseptè II TGFβ negatif dominan ak TIM3 tronke amelyore efikasite antitimoral terapi selil CAR-T nan kansè pwostat. https://www.sciencedirect.com/science/article/pii/S1567576923011323
Non pwodwi: Anti-imen CD28mAb Nimewo atik: GMP-TL102 Reseptè II TGFβ negatif dominan ak TIM3 tronke amelyore efikasite antitimoral terapi selil CAR-T nan kansè pwostat. https://www.sciencedirect.com/science/article/pii/S1567576923011323
Non pwodwi: Twous kilti selil AMMS®NK Selil CAR-T bisistronik ki vize CD123 ak CLL1 pou AML pou diminye risk pou antijèn chape. https://www.sciencedirect.com/science/article/pii/S1936523323000815
Non pwodwi: Pwoteyin IFN-γ imen rekombinan Nimewo atik: GMP-TL105 miR-1187 pwovoke blesi podosit ak nefropati dyabetik atravè otofaji https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10201642/
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 DOI: 10.3969/j.issn.1671-2587.2023.03.006 http://www.lcsxyjy.com/CN/Y2023/V25/I3/320
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 DOI: 10.3969/j.issn.1671-2587.2023.03.006 http://www.lcsxyjy.com/CN/Y2023/V25/I3/320
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 Selil CAR-T ki vize B7-H3 yo montre yon fonksyon anti-timoral trè efikas kont osteosarkòm ni in vitro ni in vivo. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10229-8
Non pwodwi: Anti-imen CD28mAb Nimewo atik: GMP-TL102 Selil CAR-T ki vize B7-H3 yo montre yon fonksyon anti-timoral trè efikas kont osteosarkòm ni in vitro ni in vivo. https://bmccancer.biomedcentral.com/articles/10.1186/s12885-022-10229-8
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 Romidepsin amelyore kapasite touye selil NKG2D-CAR-T yo atravè yon ekspresyon amelyore de NKG2DL kont selil kansè nan ovè. https://www.imrpress.com/journal/CEOG/49/10/10.31083/j.ceog4910227/htm
Non pwodwi: Pwoteyin IFN-γ imen rekombinan Nimewo atik: GMP-TL105 Konplanatusid soulaje domaj selil enflamatwa ki pwovoke pa sitokin pro-enflamatwa nan keratinosit po yo. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9399639/
non pwodwi: Pwoteyin IL-5 imen rekombinan Nimewo atik: GMP-TL754 DOI:10.27272/d.cnki.gshdu.2022.000433. https://www.zhangqiaokeyan.com/academic-degree-domestic_mphd_thesis/020315252241.html
Non pwodwi: Pwoteyin IL-1β imen rekombinan Nimewo atik: GMP-TL513 DOI:10.27272/d.cnki.gshdu.2022.000433. https://www.zhangqiaokeyan.com/academic-degree-domestic_mphd_thesis/020315252241.html
Non pwodwi: Pwoteyin IFN-γ imen rekombinan Nimewo atik: GMP-TL105 Sond fliyoresan pH imobilize ak mitokondri ki baze sou piperazin pou imaj ONOO andojèn ak swiv mitofaji an tan reyèl. https://pubs.acs.org/doi/abs/10.1021/acsabm.2c00213
Non pwodwi: Pwoteyin CSF-Imèn Rekombinan GM Nimewo atik: GMP-TL302 DOI:10.27170/d.cnki.gjsuu.2022.000908. https://cdmd.cnki.com.cn/Article/CDMD-10299-1022583126.htm
non pwodwi: Pwoteyin IL-4 imen rekombinan Nimewo atik: GMP-TL301 DOI:10.27170/d.cnki.gjsuu.2022.000908. https://cdmd.cnki.com.cn/Article/CDMD-10299-1022583126.htm
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 doi: 10.13303 /j.cjbt. issn. 1004-549x. 2022.08.010 https://www.nstl.gov.cn/paper_detail.html?id=5638a20c5237a010b325feea8836a6eb
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 doi: 10.13303 /j.cjbt. issn. 1004-549x. 2022.08.010 https://www.nstl.gov.cn/paper_detail.html?id=5638a20c5237a010b325feea8836a6eb
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 DOI:10.26998/d.cnki.gjuyu.2022.000131. https://d.wanfangdata.com.cn/thesis/D02790739
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 DOI:10.26998/d.cnki.gjuyu.2022.000131. https://d.wanfangdata.com.cn/thesis/D02790739
Non pwodwi: Anti-imen CD28mAb Nimewo atik: GMP-TL102 DOI:10.26998/d.cnki.gjuyu.2022.000131. https://d.wanfangdata.com.cn/thesis/D02790739
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 DOI:10.27262/d.cnki.gqdau.2022.000392. https://d.wanfangdata.com.cn/thesis/D02865862
non pwodwi: Pwoteyin IL-12 imen rekombinan Nimewo atik: GMP-TL508 DOI:10.27262/d.cnki.gqdau.2022.000392. https://d.wanfangdata.com.cn/thesis/D02865862
non pwodwi: Pwoteyin IL-15 imen rekombinan Nimewo atik: GMP-TL202 DOI:10.27262/d.cnki.gqdau.2022.000392. https://d.wanfangdata.com.cn/thesis/D02865862
non pwodwi: Pwoteyin IL-21 imen rekombinan Nimewo atik: GMP-TL509 DOI:10.27262/d.cnki.gqdau.2022.000392. https://d.wanfangdata.com.cn/thesis/D02865862
Non pwodwi: Anti-imen CD16mAb Nimewo atik: GMP-TL201 DOI:10.27262/d.cnki.gqdau.2022.000392. https://d.wanfangdata.com.cn/thesis/D02865862
Non pwodwi: Pwoteyin HumanBMP-2 Recombinant Nimewo atik: GMP-TL634 DOI:10.27232/d.cnki.gnchu.2022.000372. https://cdmd.cnki.com.cn/Article/CDMD-10403-1022637642.htm
Non pwodwi: Pwoteyin PDGF-BB imen rekombinan Nimewo atik: GMP-TL644 DOI:10.27232/d.cnki.gnchu.2022.000372. https://cdmd.cnki.com.cn/Article/CDMD-10403-1022637642.htm
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 Liraglutid aktive repons antitimoral ki medyatè pa selil asasen natirèl yo lè li inibi siyalizasyon IL-6/STAT3 nan karsinom epatoselilè, https://www.sciencedirect.com/science/article/pii/S1936523320303648
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 10.27038/d.cnki.ggxyu.2021.000719. https://wap.cnki.net/touch/web/Dissertation/Article/1022009152.nh.html
Non pwodwi: Anti-imen CD28mAb Nimewo atik: GMP-TL102 10.27038/d.cnki.ggxyu.2021.000719. https://wap.cnki.net/touch/web/Dissertation/Article/1022009152.nh.html
Non pwodwi: Pwoteyin HumanHER2 Recombinant Nimewo atik: GMP-TL734 DOI:10.27169/d.cnki.gwqgu.2021.001008. http://cdmd.cnki.com.cn/Article/CDMD-10295-1021757302.htm
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 DOI:10.27648/d.cnki.gzxhu.2021.000589 https://cdmd.cnki.com.cn/Article/CDMD-10023-1021169654.htm
Non pwodwi: Anti-imen CD28mAb Nimewo atik: GMP-TL102 DOI:10.27819/d.cnki.gzgjl.2021.000573. https://read.cnki.net/web/Dissertation/Article/10356-1021159713.nh.html
Non pwodwi: Pwoteyin SCF imen rekombinan Nimewo atik: GMP-TL504 DOI:10.27466/d.cnki.gzzdu.2021.001720. https://d.wanfangdata.com.cn/thesis/Y3844118
Non pwodwi: Anti-imen CD3mAb Nimewo atik: GMP-TL101 Ekspansyon lenfosit ki enfiltre timè (TIL) ak pwopriyete souch sibstansyèl ki soti nan kansè vulvè https://www.gavinpublishers.com/article/view/expansion-of-tumor-infiltrating-lymphocytes--tils-with-substantial-stemness-properties--from-vulvar-cancer
non pwodwi: Pwoteyin IL-2 imen rekombinan Nimewo atik: GMP-TL906 Ekspansyon lenfosit ki enfiltre timè (TIL) ak pwopriyete souch sibstansyèl ki soti nan kansè vulvè https://www.gavinpublishers.com/article/view/expansion-of-tumor-infiltrating-lymphocytes--tils-with-substantial-stemness-properties--from-vulvar-cancer